Literature DB >> 10800805

Axillary artery cannulation in acute ascending aortic dissections.

J D Whitlark1, S M Goldman, F P Sutter.   

Abstract

BACKGROUND: Standard cannulation of the femoral artery in preparation for repair of a dissection involving the ascending aorta carries a high risk of malperfusion. Arterial perfusion through the right axillary artery is more likely to perfuse the true lumen and should be advantageous in acute dissections involving the ascending aorta.
METHODS: Thirteen patients underwent repair of acute ascending aortic dissections and were perfused through the right axillary artery. All had deep hypothermic circulatory arrest.
RESULTS: There was one mild intraoperative cerebrovascular accident with complete recovery and one operative death secondary to low cardiac output. There were no intraoperative problems with perfusion through the axillary artery, and there were no postoperative problems or complications involving the axillary artery, axillary vein, or brachial plexus.
CONCLUSIONS: Arterial perfusion through the right axillary artery is a safe and effective means of more reliably perfusing the true lumen. In this regard, it may be superior to femoral artery perfusion and could lead to improved outcomes with repair of acute deBakey type I and II aortic dissections.

Entities:  

Mesh:

Year:  2000        PMID: 10800805     DOI: 10.1016/s0003-4975(99)01434-4

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  9 in total

1.  Left common carotid artery cannulation for type A aortic dissections.

Authors:  Yoshihiko Mochizuki; Hiroshi Iida; Hideaki Mori; Yasuyuki Yamada; Shinichiro Miyoshi
Journal:  Tex Heart Inst J       Date:  2003

2.  Intraoperative descending aortic dissection during aortic root replacement: successful management.

Authors:  Anton A Gryaznov; Wei-Guo Ma; Young Erben; Mohammad A Zafar; Camilo A Velasquez; Ayman Saeyeldin; Bulat A Ziganshin; John A Elefteriades
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

3.  Direct versus side-graft cannulation of the right axillary artery for antegrade cerebral perfusion.

Authors:  Levent Yilik; Bilgin Emrecan; Mert Kestelli; Ibrahim Ozsoyler; Banu Lafci; Necmettin Yakut; Cengiz Ozbek; Ali Gurbuz
Journal:  Tex Heart Inst J       Date:  2006

4.  Right axillary artery cannulation for surgical management of the hostile ascending aorta.

Authors:  John Kokotsakit; George Lazopoulos; Michael Milonakis; George Athanasiadis; Konstantina Romana; Elian Skouteli; Elias Bastounis
Journal:  Tex Heart Inst J       Date:  2005

5.  Left thoracotomy approach in reoperative off-pump coronary revascularization: bypass grafting from the left axillary artery or descending thoracic aorta.

Authors:  Masahito Minakawa; Kenji Takahashi; Norihiro Kondo; Masaharu Hatakeyama; Toshihiko Kuga; Ikuo Fukuda
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-11

6.  Direct Axillary Arterial Cannulation Using Seldinger's Technique in Aortic Dissection.

Authors:  Young Woo Do; Gun-Jik Kim; Il Park; Joon-Yong Cho; Jong-Tae Lee
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2011-10-06

7.  Central cannulation by Seldinger technique: a reliable method in ascending aorta and aortic arch replacement.

Authors:  Laszlo Göbölös; Peter Ugocsai; Maik Foltan; Alois Philipp; Andrea Thrum; Szabolcs Miskolczi; Pietro G Malvindi; Vincenzo di Gregorio; Dimitrios Pousios; Manoraj Navaratnarajah; Sunil K Ohri
Journal:  Med Sci Monit       Date:  2014-11-22

8.  Double arterial cannulation strategy for acute type A aortic dissection repair: A 10-year single-institution experience.

Authors:  Chun-Yu Lin; Chi-Nan Tseng; Hsiu-An Lee; Heng-Tsan Ho; Feng-Chun Tsai
Journal:  PLoS One       Date:  2019-02-06       Impact factor: 3.240

9.  Direct true lumen cannulation in type A acute aortic dissection: A review of an 11 years' experience.

Authors:  Hazem El Beyrouti; Daniel-Sebastian Dohle; Mohammad Bashar Izzat; Lena Brendel; Philipp Pfeiffer; Christian-Friedrich Vahl
Journal:  PLoS One       Date:  2020-10-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.